ğŸŒ… U.S. MARKET OPEN ğŸ“Š

ğŸŒ± ğŸŒ± ğŸŒ± ğŸŒ¿ SLIGHT GAINS: +0.18% ğŸŒ± ğŸŒ± ğŸŒ±

TOP 5 TODAY PERFORMANCE OF PORTFOLIO ğŸ“ˆ
ğŸ›¢ï¸ $MAU.PA +8.12%
ğŸ­ $TSM +2.24%
ğŸ“Š $SX7PEX.DE +1.25%
ğŸ”‹ $ENEL.MI +0.71%
ğŸ”Œ $PRY.MI +0.70%

TOP 3 MONTHLY PERFORMANCE OF PORTFOLIO ğŸ“ˆ
ğŸ–¥ï¸ $SNPS +22.77%
â›ï¸ $GLEN.L +14.31%
ğŸ›¢ï¸ $MAU.PA +12.66%

TOP 3 HOLDING YEARLY PERFORMANCE OF PORTFOLIO ğŸ“ˆ
ğŸ›¡ï¸ $PLTR +139.76%
â˜ï¸ $NET +78.02%
âš¡ $CCJ +76.36%

ğŸŒ MARKET NEWS RECAP

Global markets traded with a modest year-end pullback amid extremely thin holiday volumes, with US $S&P 500 and $Nasdaq 100 futures signaling a soft open, down 0.2% and 0.3% respectively. European bourses were similarly muted, as the Stoxx Europe 600 fell 0.1% and France's CAC 40 declined 0.4% in early trading. In Asia, the $Shanghai Composite managed a marginal gain of 0.1%, contrasting with a 0.9% drop in the Hang Seng index, as investors booked profits on the final trading day of the year.

ğŸ’¼ PORTFOLIO FOCUS

The AI and chip sector, which includes $NVDA, $AVGO, $TSM, $MSFT, and $SNPS, saw a major catalyst with news of $NVDA's potential $20 billion acquisition of Groq's AI inferencing technology, positioning it for the next growth phase in AI adoption. In the GLP-1 space, $NOVO-B.CO submitted a New Drug Application (NDA) to the FDA for its once-weekly CagriSema combination for weight management, intensifying competition with $LLY. Separately, a new FDA-approved motion sickness drug is being developed to treat the nausea side effects of GLP-1 agonists, a development that could improve patient adherence for $LLY and $NOVO-B.CO products. Holdings in the broader Industrial, Financial ($DB1.DE, $PYPL, $MELI), and Energy ($CCJ, $GLEN.L, $ENEL.MI) sectors traded largely in line with their respective regional index movements in the quiet year-end session.

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
ğŸ’¡ WHY COPY THIS PORTFOLIO?

ğŸ“ˆ TRACK RECORD:
+171% since strategy change (2020)
~34% average annual return
Double your money in ~2.1 years

âœ… STRATEGY HIGHLIGHTS:
â€¢ Smart diversification across 3 continents
â€¢ Focus on megatrends: AI, Healthcare, Energy
â€¢ Mix of ETFs + high-potential individual stocks
â€¢ Active and transparent management

ğŸ“Š PERFORMANCE DELTA vs. BENCHMARKS (Since 2020):
âœ“ VS $SPX500 : +60% (outperformance)
âœ“ VS $NSDQ100 : -15% (underperformance)
âœ“ VS $SWDA.L : +69% (outperformance)
âœ“ VS $EUSTX50 : +117% (outperformance)
âœ“ VS $CHINA50 : +173% (outperformance)

ğŸ¯ Long-term strategy based on solid fundamentals
ğŸ”„ Periodic rebalancing to optimize risk/reward

@AndreaRavalli
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
